Terms: = Skin cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659
9 results:
1. Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy.
Ladányi A; Rásó E; Barbai T; Vízkeleti L; Puskás LG; Kovács SA; Győrffy B; Tímár J
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269844
[TBL] [Abstract] [Full Text] [Related]
2. Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.
Cifdaloz M; Osterloh L; Graña O; Riveiro-Falkenbach E; Ximénez-Embún P; Muñoz J; Tejedo C; Calvo TG; Karras P; Olmeda D; Miñana B; Gómez-López G; Cañon E; Eyras E; Guo H; Kappes F; Ortiz-Romero PL; Rodríguez-Peralto JL; Megías D; Valcárcel J; Soengas MS
Nat Commun; 2017 Dec; 8(1):2249. PubMed ID: 29269732
[TBL] [Abstract] [Full Text] [Related]
3. dek-targeting DNA aptamers as therapeutics for inflammatory arthritis.
Mor-Vaknin N; Saha A; Legendre M; Carmona-Rivera C; Amin MA; Rabquer BJ; Gonzales-Hernandez MJ; Jorns J; Mohan S; Yalavarthi S; Pai DA; Angevine K; Almburg SJ; Knight JS; Adams BS; Koch AE; Fox DA; Engelke DR; Kaplan MJ; Markovitz DM
Nat Commun; 2017 Feb; 8():14252. PubMed ID: 28165452
[TBL] [Abstract] [Full Text] [Related]
4. dek oncogene is overexpressed during melanoma progression.
Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
[TBL] [Abstract] [Full Text] [Related]
5. dek promotes HPV-positive and -negative head and neck cancer cell proliferation.
Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
[TBL] [Abstract] [Full Text] [Related]
6. dek expression in Merkel cell carcinoma and small cell carcinoma.
Patel RM; Walters LL; Kappes F; Mehra R; Fullen DR; Markovitz DM; Ma L
J Cutan Pathol; 2012 Aug; 39(8):753-7. PubMed ID: 22765016
[TBL] [Abstract] [Full Text] [Related]
7. dek expression in melanocytic lesions.
Kappes F; Khodadoust MS; Yu L; Kim DS; Fullen DR; Markovitz DM; Ma L
Hum Pathol; 2011 Jul; 42(7):932-8. PubMed ID: 21316078
[TBL] [Abstract] [Full Text] [Related]
8. Melanoma proliferation and chemoresistance controlled by the dek oncogene.
Khodadoust MS; Verhaegen M; Kappes F; Riveiro-Falkenbach E; Cigudosa JC; Kim DS; Chinnaiyan AM; Markovitz DM; Soengas MS
Cancer Res; 2009 Aug; 69(16):6405-13. PubMed ID: 19679545
[TBL] [Abstract] [Full Text] [Related]
9. Cytokeratin contents of basal cell carcinoma, epidermis overlying tumour, and associated stromal amyloidosis: an immunohistochemical study.
Apaydin R; Gürbüz Y; Bayramgürler D; Bilen N
Amyloid; 2005 Mar; 12(1):41-7. PubMed ID: 16076610
[TBL] [Abstract] [Full Text] [Related]
